BlossomHill Therapeutics, Inc. (BLSM) has filed proposed terms for its $125 million IPO, according to an amended S-1/A registration statement. The company is a clinical-stage biopharma developing ...
Researchers from the Rolf Luft Research Center for Diabetes and Endocrinology at Karolinska Institutet have developed a ...
It’s no secret that modern humans and Neanderthals interbred: most of the world’s population today has around 1 or 2 percent ...
Matt Walker couldn't pet a dog without sneezing — until he and other scientists used a gene editing technique to produce a ...
To find the gene, scientists sequenced the coding DNA of more than a million people across three continents, scouring for ...
Ten years and thousands of patient samples later, the National Cancer Institute (NCI) has published its results from the ...
Healthcare advocates and health-conscious Nigerians gathered in Ikeja, Lagos, over the weekend for the PhytoScience Nigeria Convention ...
From routine surgeries to cancer treatment, modern medicine depends on drugs that can fight infections caused by microbes ...
What parents should do when they get a call from their teen who has a problem. How to advise your student if you get that ...
Jenks Public Schools Superintendent Dr. Stacey Butterfield discusses the completion of the Freshman Academy, Oklahoma's new ...
Here are the latest biotech industry updates, including the program announcement for The Antibody Series 2026.
A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results